Gastric Antrum Discomfort: Evaluation and Management
For a patient presenting with gastric antrum discomfort, test for H. pylori and initiate eradication therapy if positive; if negative or symptoms persist after treatment, start a proton pump inhibitor at the lowest effective dose. 1
Initial Evaluation and Risk Stratification
The evaluation hinges on identifying alarm features that warrant urgent investigation versus functional disease that can be managed empirically:
When to Perform Urgent Endoscopy
- Age ≥55 years with weight loss - requires urgent endoscopy 1
- Age >40 years with family history of gastro-oesophageal cancer - requires urgent endoscopy 1
- Age ≥60 years with abdominal pain AND weight loss - consider urgent abdominal CT to exclude pancreatic cancer 1
When to Consider Non-Urgent Endoscopy
- Age ≥55 years with treatment-resistant dyspepsia 1
- Age ≥55 years with raised platelet count, nausea, or vomiting 1
Critical pitfall: Alarm features have limited utility in predicting endoscopic findings, and most patients will have no organic pathology identified 2. However, they remain the standard for triaging access to investigation.
First-Line Management Algorithm
Step 1: H. pylori Testing (All Patients Without Alarm Features)
All patients should receive non-invasive H. pylori testing (stool antigen or breath test) 1. This is a strong recommendation based on high-quality evidence.
- If H. pylori positive: Prescribe eradication therapy - this is highly efficacious with strong evidence 1
- If H. pylori negative OR symptoms persist after eradication: Proceed to Step 2
Step 2: Empirical Acid Suppression
Start a proton pump inhibitor (PPI) at the lowest dose that controls symptoms for up to 8 weeks 1, 2. This carries a strong recommendation with high-quality evidence. There is no dose-response relationship, so avoid unnecessarily high doses 1.
Alternative: H2-receptor antagonists may be used but have weaker evidence (weak recommendation, low-quality evidence) 1.
Step 3: Lifestyle Modifications
Advise regular aerobic exercise - strong recommendation despite very low-quality evidence 1. Avoid overly restrictive diets as there is insufficient evidence for specialized dietary therapies including low-FODMAP diets 1.
Second-Line Treatment (If Symptoms Persist After 8 Weeks)
Initiate a tricyclic antidepressant (TCA) as a gut-brain neuromodulator 1. This is a strong recommendation with moderate-quality evidence:
- Start amitriptyline 10 mg once daily
- Titrate slowly to maximum 30-50 mg once daily
- Continue for 6-12 months in responders 2
- Essential: Explain the rationale clearly (neuromodulation, not depression treatment) and counsel about side effects 1
Alternative second-line options with weaker evidence include:
- Prokinetics (tegaserod has moderate evidence; acotiamide, itopride, mosapride have low evidence) 1
- Antipsychotics (sulpiride 100 mg four times daily or levosulpiride 25 mg three times daily) 1
When to Refer to Gastroenterology
Referral is appropriate when 1:
- Diagnostic uncertainty exists
- Symptoms are severe or refractory to first-line treatments
- Patient requests specialist opinion
Avoid routine gastric emptying testing or 24-hour pH monitoring in typical functional dyspepsia - strong recommendation 1.
Management of Refractory Disease
For severe or treatment-resistant cases:
- Involve a multidisciplinary team (gastroenterologist, dietitian, psychologist) - strong recommendation 1
- Screen for eating disorders including avoidant restrictive food intake disorder (ARFID) if weight loss and food restriction present 1
- Early dietitian involvement to prevent overly restrictive diets and malnutrition 1
- Avoid opioids and surgery to minimize iatrogenic harm - strong recommendation 1
- Consider psychological/behavioral therapies where available 2
Key Clinical Pitfalls
- Don't over-investigate: Most patients have functional disease; normal endoscopy doesn't mean "nothing is wrong" - it reflects gut-brain axis dysfunction 1
- Don't delay H. pylori testing: This is the only intervention with high-quality evidence for efficacy 1, 2
- Don't use high-dose PPIs: No dose-response exists; use the lowest effective dose 1
- Don't restrict diet excessively: Can lead to malnutrition and disordered eating 1
- Don't resort to surgery: Reserved only for carefully selected cases with structural pathology 1